Literature DB >> 1634809

Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.

D R Johnson1, D L Stevens, E L Kaplan.   

Abstract

More than 1100 group A streptococcal isolates collected in the United States (1988-1990) were examined to document an association of individual serotypes with specific clinical infections during the recent resurgence of group A infections and their sequelae. The most commonly isolated strains from patients with only uncomplicated streptococcal pharyngitis ("control" strains) were M serotypes 1, 2, 4, and 12. M1, M3, and M18 were statistically significantly more frequently isolated from patients with serious invasive infections and M3 and M18 from patients with rheumatic fever compared with the distribution of serotypes from the 866 control strains. An unexpected and important finding indicated that isolation rates of M1 streptococci varied geographically within the United States by year. The propensity for M1 streptococci to be statistically associated with severe systemic infections appeared unrelated to the M1 isolation rates from patients with only uncomplicated pharyngitis, thus offering additional support for the concept of strain-associated virulence rather than virulence broadly related to a given serotype.

Entities:  

Mesh:

Year:  1992        PMID: 1634809     DOI: 10.1093/infdis/166.2.374

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  85 in total

1.  Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.

Authors:  M Roggiani; J A Stoehr; S B Olmsted; Y V Matsuka; S Pillai; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes.

Authors:  Awdhesh Kalia; Brian G Spratt; Mark C Enright; Debra E Bessen
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong.

Authors:  P L Ho; D R Johnson; A W Y Yue; D N C Tsang; T L Que; B Beall; E L Kaplan
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Betty Forwick; Nancy P Hoe; James M Musser; James A Talbot
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  New protective antigen of group A streptococci.

Authors:  J B Dale; E Y Chiang; S Liu; H S Courtney; D L Hasty
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

7.  National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites.

Authors:  Christopher P Barrozo; Kevin L Russell; Tyler C Smith; Anthony W Hawksworth; Margaret A K Ryan; Gregory C Gray
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

8.  Streptococcus pyogenes Ser/Thr kinase-regulated cell wall hydrolase is a cell division plane-recognizing and chain-forming virulence factor.

Authors:  Vijay Pancholi; Gregory Boël; Hong Jin
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

9.  The group A streptococcal virR49 gene controls expression of four structural vir regulon genes.

Authors:  A Podbielski; A Flosdorff; J Weber-Heynemann
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.

Authors:  S Le Hello; A Doloy; F Baumann; N Roques; P Coudene; B Rouchon; F Lacassin; A Bouvet
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.